Cora Capital Advisors LLC Astrazeneca PLC Transaction History
Cora Capital Advisors LLC
- $203 Billion
- Q3 2024
A detailed history of Cora Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cora Capital Advisors LLC holds 4,184 shares of AZN stock, worth $277,190. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,184
Previous 4,184
-0.0%
Holding current value
$277,190
Previous $326 Million
0.1%
% of portfolio
0.16%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.78 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $205B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...